Filing metadata

Accession number
0001415889-25-022974
Form type
Form 3
Filer
KalVista Pharmaceuticals, Inc.
CIK
CIK 1348911
Filed
Aug 25, 2025
Reporting period
Jun 18, 2025
Description
Initial ownership

Explore SEC Filings Hub